Fully vaccinated adults can harbour virus levels as high as unvaccinated people if infected with the Delta variant, according to a sweeping analysis of UK data, which supports the idea that hitting the threshold for herd immunity is unlikely.
There is abundant evidence that Covid vaccines in the UK continue to offer significant protection against hospitalisations and death. But this new analysis shows that although being fully vaccinated means the risk of getting infected is lower, once infected by Delta a person can carry similar virus levels as unvaccinated people.
The implications of this on transmission remain unclear, the researchers have cautioned. “We don’t yet know how much transmission can happen from people who get Covid-19 after being vaccinated – for example, they may have high levels of virus for shorter periods of time,” said Sarah Walker, a professor of medical statistics and epidemiology at the University of Oxford.
“But the fact that they can have high levels of virus suggests that people who aren’t yet vaccinated may not be as protected from the Delta variant as we hoped.”
Positive tests, hospitalisations and deaths linked to Covid have been rising slowly in the UK recently. In the week to 18 August, 211,238 people had a confirmed positive test result, an increase of 7.6% compared with the previous seven days. Over the same period, there have been 655 deaths within 28 days of a positive test, a rise of 7.9% versus the previous seven days. Hospitalisations have also risen slightly, with 5,623 going into hospital with coronavirus between 8 August 2021 and 14 August 2021, a rise of 4.3% compared with the previous seven days.
The study, which is yet to be peer-reviewed, found vaccine performance has waned against Delta versus the previously dominant Alpha variant.
The analysis did not directly investigate whether the lower level of vaccine protection against Delta affected jabs’ ability to prevent severe disease. However, Dr Penny Ward, a visiting professor in pharmaceutical medicine at King’s College London, noted: “The low incidence of hospitalisation seen to date suggests that in this respect at least the vaccines are protecting individuals from developing severe Covid.”
The study – conducted by Oxford researchers in partnership with the Office for National Statistics and the Department of Health and Social Care – compared the results of about 2.6m nose and throat swabs taken from more than 384,500 adults between December 2020 and mid-May 2021, and more than 811,600 test results from 358,983 adults between mid-May and 1 August 2021 (the period of Delta’s domination).
The UK findings on peak virus levels after Delta infections in vaccinated people echoed data from a small study cited by the US Centers for Disease Control and Prevention (CDC) last month. The agency indicated those findings had underpinned its decision to recommend that people wear masks in some indoor settings, regardless of their vaccination status, especially in areas of “substantial or high” virus transmission.
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]